LHRH antagonists vs LHRH agonists: Which is more beneficial in prostate cancer therapy?

Daniel Keizman, Mario A. Eisenberger

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)631-632
Number of pages2
JournalONCOLOGY
Volume23
Issue number7
StatePublished - Jun 1 2009

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this